Dr. Kanwar R. S. Gill, MD

Dr. Gill practices at San Ramon Endoscopy Center - HOPD in San Ramon, California.

Dr. Gill's NPI, 1861409385, was assigned on August 1, 2006. Dr. Gill graduated from Government Medical College Amritsar in 2001. Dr. Gill holds California license A92249.

Dr. Gill's primary practice is San Ramon Endoscopy Center - HOPD, at 5801 Norris Canyon Rd, San Ramon, CA 94583.

Dr. Gill's primary practice is San Ramon Endoscopy Center - HOPD in San Ramon, California. Dr. Gill is also affiliated with San Ramon Regional Medical Center. The medical group on file is John Muir Health. Dmand AI also links Dr. Gill to 2 more hospitals, 3 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gill practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gill's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gill is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gill's licenses on file in 2 states: California and Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, esophagus, stomach, or upper small intestine surgery, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Gill treats.

CMS data shows 2,233 Medicare services from Dr. Gill across 24 procedure codes in 2024, for 879 Medicare patients. Medicare paid $246,818 for them.

CMS counts 879 Medicare patients who saw Dr. Gill in 2024. The largest group is 65 to 74, with 384 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gill's median patient age at 62, with 52% women.

In 2024, Dr. Gill wrote 2,372 Medicare Part D claims for 756 patients. 81% of them were for generic drugs. CMS names the drug for 2,106 of them, across 38 drugs with 11 or more claims each, at $1,594,173 in total drug cost. In 2023, CMS named 1,948 claims across 41 drugs.

Dr. Gill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gill as offering telehealth. CMS counts 525 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gill, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 35 papers to Dr. Gill, published from 2009 to 2020. 2009 was the busiest year, with 9. The most frequent topics are Endosonography, Biopsy, Fine-Needle and Pancreatic Neoplasms. Dr. Gill has published most often in Gastrointest Endosc. Dr. Gill's most frequent co-authors are Michael B. Wallace, MD, Massimo Raimondo, MD and Timothy Woodward, MD.

CMS Open Payments shows 903 general payments to Dr. Gill from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Abbvie Inc. paid the most, $122,184.

Dmand AI lists 5 awards for Dr. Gill, most recently Specialist of the Year in 2017.

Dr. Gill graduated from Government Medical College Amritsar in 2001.

Dr. Gill is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.